UPDATE 2-Epizyme prices rare tissue cancer treatment at $15,500 a month
January 23, 2020 at 18:34 PM EST
Epizyme Inc on Thursday priced its treatment for a ultra rare, slow growing type of cancer that affects soft tissue at $15,500 per month after getting an approval from the U.S. Food and Drug Administration.
